These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31477221)

  • 21. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
    Alguel G; Vormittag R; Simanek R; Kyrle PA; Quehenberger P; Mannhalter C; Husslein P; Pabinger I
    Thromb Haemost; 2006 Sep; 96(3):285-9. PubMed ID: 16953268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Features of CVT in Women and Effect on Subsequent Pregnancy: A Follow-Up Study in a Chinese National Comprehensive Hospital.
    Wu YT; Zhou LX; Yao M; Ni J; Zhu YC; Cui LY; Peng B
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105274. PubMed ID: 33066887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
    Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Bates SM; Greer IA; Hirsh J; Ginsberg JS
    Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary thrombophilia in cerebral venous thrombosis: a study from India.
    Pai N; Ghosh K; Shetty S
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):540-3. PubMed ID: 23518830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium.
    Mitić G; Kovac M; Povazan L; Djordjević V; Ilić V; Salatić I; Lazić R; Antonijević N; Novakov-Mikić A
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():18-22. PubMed ID: 20229677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombosis of the cerebral veins in gynecological practice].
    Makatsaria AD; Akin'shina SV; Bitsadze VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8 Pt 2):33-39. PubMed ID: 28635764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study.
    Lazo-Langner A; Al-Ani F; Weisz S; Rozanski C; Louzada M; Kovacs J; Kovacs MJ
    Thromb Res; 2018 Jul; 167():20-25. PubMed ID: 29772489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
    Gessler F; Bruder M; Duetzmann S; Tritt S; Bernstock JD; Seifert V; Senft C
    J Neurosurg; 2018 Feb; 128(2):373-379. PubMed ID: 28387630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.
    Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH
    Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
    Paskaleva I; Karagiozova Zh; Doncheva E; Dineva D
    Akush Ginekol (Sofiia); 2014; 53(2):3-10. PubMed ID: 25098102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline.
    Weimar C; Beyer-Westendorf J; Bohmann FO; Hahn G; Halimeh S; Holzhauer S; Kalka C; Knoflach M; Koennecke HC; Masuhr F; Mono ML; Nowak-Göttl U; Scherret E; Schlamann M; Linnemann B
    Neurol Res Pract; 2024 Apr; 6(1):23. PubMed ID: 38637841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low molecular weight heparins: a guide to their optimum use in pregnancy.
    Laurent P; Dussarat GV; Bonal J; Jego C; Talard P; Bouchiat C; Cellarier G
    Drugs; 2002; 62(3):463-77. PubMed ID: 11827560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
    Bauersachs RM; Dudenhausen J; Faridi A; Fischer T; Fung S; Geisen U; Harenberg J; Herchenhan E; Keller F; Kemkes-Matthes B; Schinzel H; Spannagl M; Thaler CJ;
    Thromb Haemost; 2007 Dec; 98(6):1237-45. PubMed ID: 18064320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
    Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
    Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
    Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
    Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
    Selmeczi A; Roach RE; Móré C; Batta Z; Hársfalvi J; van der Bom JG; Boda Z; Oláh Z
    Thromb Haemost; 2015 Feb; 113(2):283-9. PubMed ID: 25392852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombophilia, thrombosis and pregnancy.
    Eldor A
    Thromb Haemost; 2001 Jul; 86(1):104-11. PubMed ID: 11486995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.